![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMCO6 |
Gene summary for TMCO6 |
![]() |
Gene information | Species | Human | Gene symbol | TMCO6 | Gene ID | 55374 |
Gene name | transmembrane and coiled-coil domains 6 | |
Gene Alias | PRO1580 | |
Cytomap | 5q31.3 | |
Gene Type | protein-coding | GO ID | GO:0006606 | UniProtAcc | Q96DC7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55374 | TMCO6 | LZE24T | Human | Esophagus | ESCC | 6.85e-08 | 2.26e-01 | 0.0596 |
55374 | TMCO6 | P2T-E | Human | Esophagus | ESCC | 6.54e-16 | 1.37e-01 | 0.1177 |
55374 | TMCO6 | P4T-E | Human | Esophagus | ESCC | 5.78e-04 | 1.83e-01 | 0.1323 |
55374 | TMCO6 | P5T-E | Human | Esophagus | ESCC | 2.50e-07 | 1.03e-01 | 0.1327 |
55374 | TMCO6 | P8T-E | Human | Esophagus | ESCC | 5.57e-05 | 1.11e-01 | 0.0889 |
55374 | TMCO6 | P10T-E | Human | Esophagus | ESCC | 8.63e-06 | 8.43e-02 | 0.116 |
55374 | TMCO6 | P12T-E | Human | Esophagus | ESCC | 1.84e-18 | 3.61e-01 | 0.1122 |
55374 | TMCO6 | P15T-E | Human | Esophagus | ESCC | 3.25e-11 | 2.66e-01 | 0.1149 |
55374 | TMCO6 | P16T-E | Human | Esophagus | ESCC | 4.79e-11 | 1.55e-01 | 0.1153 |
55374 | TMCO6 | P20T-E | Human | Esophagus | ESCC | 6.13e-17 | 4.03e-01 | 0.1124 |
55374 | TMCO6 | P21T-E | Human | Esophagus | ESCC | 3.48e-13 | 1.77e-01 | 0.1617 |
55374 | TMCO6 | P22T-E | Human | Esophagus | ESCC | 5.27e-13 | 1.84e-01 | 0.1236 |
55374 | TMCO6 | P23T-E | Human | Esophagus | ESCC | 2.87e-06 | 1.79e-01 | 0.108 |
55374 | TMCO6 | P24T-E | Human | Esophagus | ESCC | 2.24e-17 | 1.52e-01 | 0.1287 |
55374 | TMCO6 | P26T-E | Human | Esophagus | ESCC | 8.92e-11 | 1.91e-01 | 0.1276 |
55374 | TMCO6 | P27T-E | Human | Esophagus | ESCC | 1.55e-07 | 1.20e-01 | 0.1055 |
55374 | TMCO6 | P28T-E | Human | Esophagus | ESCC | 4.19e-07 | 1.38e-01 | 0.1149 |
55374 | TMCO6 | P30T-E | Human | Esophagus | ESCC | 2.43e-05 | 2.29e-01 | 0.137 |
55374 | TMCO6 | P31T-E | Human | Esophagus | ESCC | 6.81e-07 | 1.45e-01 | 0.1251 |
55374 | TMCO6 | P32T-E | Human | Esophagus | ESCC | 1.62e-08 | 1.14e-01 | 0.1666 |
Page: 1 2 3 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0072594110 | Esophagus | ESCC | establishment of protein localization to organelle | 311/8552 | 422/18723 | 3.02e-32 | 2.13e-29 | 311 |
GO:0006913110 | Esophagus | ESCC | nucleocytoplasmic transport | 230/8552 | 301/18723 | 6.04e-28 | 2.02e-25 | 230 |
GO:0051169110 | Esophagus | ESCC | nuclear transport | 230/8552 | 301/18723 | 6.04e-28 | 2.02e-25 | 230 |
GO:003450418 | Esophagus | ESCC | protein localization to nucleus | 211/8552 | 290/18723 | 4.06e-21 | 6.60e-19 | 211 |
GO:001703818 | Esophagus | ESCC | protein import | 149/8552 | 206/18723 | 5.90e-15 | 3.31e-13 | 149 |
GO:005117014 | Esophagus | ESCC | import into nucleus | 111/8552 | 159/18723 | 5.69e-10 | 1.44e-08 | 111 |
GO:000660613 | Esophagus | ESCC | protein import into nucleus | 108/8552 | 155/18723 | 1.16e-09 | 2.77e-08 | 108 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMCO6 | SNV | Missense_Mutation | c.1422A>C | p.Gln474His | p.Q474H | Q96DC7 | protein_coding | deleterious(0.02) | possibly_damaging(0.549) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMCO6 | SNV | Missense_Mutation | novel | c.1369T>C | p.Phe457Leu | p.F457L | Q96DC7 | protein_coding | tolerated(0.15) | probably_damaging(0.994) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
TMCO6 | SNV | Missense_Mutation | novel | c.1062N>A | p.Phe354Leu | p.F354L | Q96DC7 | protein_coding | tolerated(0.62) | benign(0.389) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
TMCO6 | SNV | Missense_Mutation | rs777037877 | c.331N>T | p.Arg111Trp | p.R111W | Q96DC7 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-EY-A549-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMCO6 | SNV | Missense_Mutation | novel | c.995N>T | p.Thr332Ile | p.T332I | Q96DC7 | protein_coding | tolerated(0.1) | benign(0.013) | TCGA-EY-A549-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMCO6 | insertion | Frame_Shift_Ins | novel | c.145_146insC | p.Glu51ArgfsTer48 | p.E51Rfs*48 | Q96DC7 | protein_coding | TCGA-DF-A2KY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD | ||
TMCO6 | insertion | Frame_Shift_Ins | novel | c.722_723insCACAG | p.Leu243AlafsTer81 | p.L243Afs*81 | Q96DC7 | protein_coding | TCGA-DD-AADL-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
TMCO6 | SNV | Missense_Mutation | novel | c.1027C>A | p.Arg343Ser | p.R343S | Q96DC7 | protein_coding | deleterious(0) | probably_damaging(0.969) | TCGA-55-7911-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
TMCO6 | SNV | Missense_Mutation | c.478N>T | p.Ser160Cys | p.S160C | Q96DC7 | protein_coding | deleterious(0) | possibly_damaging(0.487) | TCGA-55-A48X-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | PD | |
TMCO6 | SNV | Missense_Mutation | novel | c.357C>G | p.Ser119Arg | p.S119R | Q96DC7 | protein_coding | deleterious(0.03) | possibly_damaging(0.447) | TCGA-73-A9RS-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | carboplatin | PD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |